Other OTC - Delayed Quote • USD
Better Therapeutics, Inc. (BTTX)
At close: April 26 at 3:53 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 1 | 1 |
| Avg. Estimate | -0.12 | 0 | -0.81 | -1 |
| Low Estimate | -0.12 | 0 | -0.81 | -1 |
| High Estimate | -0.12 | 0 | -0.81 | -1 |
| Year Ago EPS | -0.37 | -0.39 | -1.69 | -0.81 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | 3.8M |
| Low Estimate | -- | -- | -- | 3.8M |
| High Estimate | -- | -- | -- | 3.8M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 12/31/2022 | 3/31/2023 | 6/30/2023 | 9/30/2023 |
|---|---|---|---|---|
| EPS Est. | -0.51 | -0.74 | -0.31 | -0.19 |
| EPS Actual | -0.37 | -0.39 | -0.24 | -0.15 |
| Difference | 0.14 | 0.35 | 0.07 | 0.04 |
| Surprise % | 27.50% | 47.30% | 22.60% | 21.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | -0.12 | 0 | -0.81 | -1 |
| 7 Days Ago | -0.12 | -0.17 | -0.81 | -1 |
| 30 Days Ago | -0.12 | -0.17 | -0.81 | -1 |
| 60 Days Ago | -0.12 | -0.17 | -0.81 | -1 |
| 90 Days Ago | -0.12 | -0.17 | -0.81 | -1 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | BTTX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 67.60% | -- | -- | 5.40% |
| Next Qtr. | -- | -- | -- | 10.90% |
| Current Year | 52.10% | -- | -- | 4.50% |
| Next Year | -23.50% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 10.94% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Lake Street: Buy to Buy | 8/10/2023 |
| Reiterates | Chardan Capital: Buy to Buy | 8/10/2023 |
| Maintains | Lake Street: Buy | 4/14/2023 |
| Maintains | Chardan Capital: Buy | 3/31/2023 |
| Maintains | Chardan Capital: Buy | 11/15/2022 |
| Maintains | Chardan Capital: Buy | 7/29/2022 |
Related Tickers
CLNN Clene Inc.
0.3399
-1.90%
RNAZ TransCode Therapeutics, Inc.
0.5499
+5.30%
ZVSA ZyVersa Therapeutics, Inc.
4.9900
-16.83%
BLPH Bellerophon Therapeutics, Inc.
0.0554
+0.73%
SNTI Senti Biosciences, Inc.
0.2900
+4.05%
BCEL Atreca, Inc.
0.0800
-6.43%
ICU SeaStar Medical Holding Corporation
0.4402
-8.63%
PXMD PaxMedica, Inc.
0.7398
+5.06%
CLDI Calidi Biotherapeutics, Inc.
0.1607
+0.44%
QNRX Quoin Pharmaceuticals, Ltd.
0.6375
+1.21%